Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Letters to the Editor

Correspondence re: Schoen et al., Lack of Association between Adipose Tissue Distribution, and Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 in Men and Women. Cancer Epidemiol. Biomark. Prev., 11: 581–586, 2002

Julie A. Britton, Susan L. Teitelbaum and Mary S. Wolff
Julie A. Britton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan L. Teitelbaum
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary S. Wolff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published June 2003
  • Article
  • Info & Metrics
  • PDF
Loading

We commend Schoen et al. (1) on their well-conducted study, in which the authors conclude there is no association between adiposity and either IGF-I1 or IGF binding protein-3, although there was a strong correlation between visceral adipose tissue and insulin level. It has been suggested recently that the relationship between adiposity and IGF-I may be an inverted U, i.e., nonlinear (2) . Inspection of Table 3 in Schoen et al. (1) suggests that visceral adipose tissue and some of the IGF-related measures have an inverted U-shaped relationship. If this were so, it is not surprising that both the correlation coefficients and the trend tests were not statistically significant, because both tests assume a monotonically increasing or decreasing trend. Given the increasing attention to the role of the IGF family in cancer etiology (3) , it would be informative to know whether this purported inverted U-shaped relationship exists in the Schoen et al. (1) study population. Understanding how adiposity and its characteristics influence the levels of the IGF family members provides much needed insight regarding potentially modifiable cancer risk factors.

Footnotes

  • ↵1 The abbreviations used are: IGF, insulin-like growth factor.

  • Received January 6, 2003.
  • Accepted January 15, 2003.

References

  1. ↵
    Schoen R. E., Schragin J., Weissfeld J. L., Thaete F. L., Evans R. W., Rosen C. J., Kuller L. H. Lack of association between adipose tissue distribution and IGF-1 and IGFBP-3 in men and women. Cancer Epidemiol. Biomark. Prev., 11: 581-586, 2002.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Lukanova A., Soderberg S., Stattin P., Palmqvist R., Lundin E., Biessy C., Rinaldi S., Riboli E., Hallmans G., Kaaks R. Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF- I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden). Cancer Causes Control, 13: 509-516, 2002.
    OpenUrlCrossRefPubMed
  3. ↵
    Yu H., Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst., 92: 1472-1489, 2000.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 12 (6)
June 2003
Volume 12, Issue 6
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Correspondence re: Schoen et al., Lack of Association between Adipose Tissue Distribution, and Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 in Men and Women. Cancer Epidemiol. Biomark. Prev., 11: 581–586, 2002
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Correspondence re: Schoen et al., Lack of Association between Adipose Tissue Distribution, and Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 in Men and Women. Cancer Epidemiol. Biomark. Prev., 11: 581–586, 2002
Julie A. Britton, Susan L. Teitelbaum and Mary S. Wolff
Cancer Epidemiol Biomarkers Prev June 1 2003 (12) (6) 586;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Correspondence re: Schoen et al., Lack of Association between Adipose Tissue Distribution, and Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 in Men and Women. Cancer Epidemiol. Biomark. Prev., 11: 581–586, 2002
Julie A. Britton, Susan L. Teitelbaum and Mary S. Wolff
Cancer Epidemiol Biomarkers Prev June 1 2003 (12) (6) 586;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Copy Number Variation and Ovarian Cancer Risk—Letter
  • Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk—Response
  • Shift Work, Chronotype, and Cancer Risk—Response
Show more Letters to the Editor
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement